Palliadelic Treatment to Reduce Psychological Distress in Persons With Inoperable Pancreatobiliary Cancer
Status:
Not yet recruiting
Trial end date:
2024-10-01
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to evaluate the ability to recruit and retain
participants, and to successfully conduct a psilocybin-based protocol, for a study of the
treatment of distress related to inoperable pancreatobilliary cancer. Secondary objectives
include pre/post, and longitudinal measurement of distress in intervention participants and a
paired family member who is in an observational arm.
Phase:
Phase 1
Details
Lead Sponsor:
Lou Lukas
Collaborator:
Jim Young Pancreatic Cancer Research Memorial Fund